Cargando…

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication

The angiotensin-converting enzyme 2 (ACE2) receptor is a major severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) host range determinant, and understanding SARS-CoV-2-ACE2 interactions will provide important insights into COVID-19 pathogenesis and animal model development. SARS-CoV-2 canno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adams, Lily E., Dinnon, Kenneth H., Hou, Yixuan J., Sheahan, Timothy P., Heise, Mark T., Baric, Ralph S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092278/ https://www.ncbi.nlm.nih.gov/pubmed/33727353 http://dx.doi.org/10.1128/mBio.03149-20

Ejemplares similares

SARS Coronavirus Pathogenesis and Therapeutic Treatment Design
por: Sheahan, Timothy P., et al.
Publicado: (2009)

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Busnadiego, Idoia, et al.
Publicado: (2020)

Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
por: Nascimento Conde, Jonas, et al.
Publicado: (2020)

Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines
por: Müller, Marcel A., et al.
Publicado: (2012)

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
por: Hoffmann, Markus, et al.
Publicado: (2022)

Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection
por: Edwards, Caitlin E., et al.
Publicado: (2020)

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
por: Dinnon, Kenneth H., et al.
Publicado: (2020)

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019)

SARS coronavirus and innate immunity
por: Frieman, Matthew, et al.
Publicado: (2008)

The NSP2 Proteins of Mouse Hepatitis Virus and Sars Coronavirus are Dispensable for Viral Replication
por: Graham, Rachel L., et al.
Publicado: (2006)

Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation
por: Higashi-Kuwata, Nobuyo, et al.
Publicado: (2022)

Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
por: Kovacevic, Mary P., et al.
Publicado: (2021)

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
por: Gralinski, Lisa E., et al.
Publicado: (2018)

Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis
por: Leist, Sarah R., et al.
Publicado: (2019)

Homologs of the Acinetobacter baumannii AceI Transporter Represent a New Family of Bacterial Multidrug Efflux Systems
por: Hassan, Karl A., et al.
Publicado: (2015)

Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium
por: Touret, Franck, et al.
Publicado: (2021)

Variation in Use of Repurposed Medications Among Patients With Coronavirus Disease 2019. From The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: Coronavirus Disease 2019 Registry Investigator Group
por: Garcia, Michael A., et al.
Publicado: (2021)

Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai
por: Lau, Susanna K. P., et al.
Publicado: (2020)

Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019
por: Khan, Sikandar H., et al.
Publicado: (2020)

Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients
por: Signorini, Liana, et al.
Publicado: (2021)

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

Multiple Copies of Mobile Tigecycline Resistance Efflux Pump Gene Cluster tmexC2D2.2-toprJ2 Identified in Chromosome of Aeromonas spp.
por: Wang, Cheng-Zhen, et al.
Publicado: (2022)

Altered Heart Rate Variability Early in ICU Admission Differentiates Critically Ill Coronavirus Disease 2019 and All-Cause Sepsis Patients
por: Kamaleswaran, Rishikesan, et al.
Publicado: (2021)

MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
por: Sheahan, Timothy, et al.
Publicado: (2008)

Coronavirus Genome Structure and Replication
por: Brian, D. A., et al.
Publicado: (2005)

SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020)

Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
por: Heise, Mark, et al.
Publicado: (2023)

Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements
por: Snouwaert, John N., et al.
Publicado: (2023)

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis
por: Rajendram, Prabalini, et al.
Publicado: (2021)

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
por: Leist, Sarah R., et al.
Publicado: (2020)

Endogenous IFITMs boost SARS-coronavirus 1 and 2 replication whereas overexpression inhibits infection by relocalizing ACE2
por: Xie, Qinya, et al.
Publicado: (2023)

Lethal Pediatric Cerebral Vasculitis Triggered by Severe Acute Respiratory Syndrome Coronavirus 2
por: Poisson, Kelsey E., et al.
Publicado: (2022)

Genetic Landscape of the ACE2 Coronavirus Receptor
por: Yang, Zhijian, et al.
Publicado: (2022)

Sars Coronavirus Vaccine Development
por: Baric, Ralph S., et al.
Publicado: (2006)

Risk Factors for Critical Coronavirus Disease 2019 and Mortality in Hospitalized Young Adults: An Analysis of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) Coronavirus Disease 2019 Registry
por: Tripathi, Sandeep, et al.
Publicado: (2021)

Interhospital Transfer Outcomes for Critically Ill Patients With Coronavirus Disease 2019 Requiring Mechanical Ventilation
por: Chen, Elaine, et al.
Publicado: (2021)

Extreme Dysbiosis of the Microbiome in Critical Illness
por: McDonald, Daniel, et al.
Publicado: (2016)

Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
por: Rockx, Barry, et al.
Publicado: (2010)

Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential
por: Kindler, Eveline, et al.
Publicado: (2013)

Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease
por: Stevaert, Annelies, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_93c6ufca9qjqjh04r4bt3eug1h